Order Article Reprints

Unnisa A, Chettupalli AK, Al Hagbani T, Khalid M, Jandrajupalli SB, Chandolu S, Hussain T. Development of Dapagliflozin Solid Lipid Nanoparticles as a Novel Carrier for Oral Delivery: Statistical Design, Optimization, In-Vitro and In-Vivo Characterization, and Evaluation. Pharmaceuticals. 2022; 15(5):568. https://doi.org/10.3390/ph15050568

Unnisa, Aziz, Ananda K. Chettupalli, Turki Al Hagbani, Mohammad Khalid, Suresh B. Jandrajupalli, Swarnalatha Chandolu, and Talib Hussain. 2022. "Development of Dapagliflozin Solid Lipid Nanoparticles as a Novel Carrier for Oral Delivery: Statistical Design, Optimization, In-Vitro and In-Vivo Characterization, and Evaluation" Pharmaceuticals 15, no. 5: 568. https://doi.org/10.3390/ph15050568

Unnisa, A., Chettupalli, A. K., Al Hagbani, T., Khalid, M., Jandrajupalli, S. B., Chandolu, S., & Hussain, T. (2022). Development of Dapagliflozin Solid Lipid Nanoparticles as a Novel Carrier for Oral Delivery: Statistical Design, Optimization, In-Vitro and In-Vivo Characterization, and Evaluation. Pharmaceuticals, 15(5), 568. https://doi.org/10.3390/ph15050568